Navigation Links
Senesco Expands on Preclinical Multiple Myeloma Findings
Date:6/5/2008

NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT) announced today further details of its continuing preclinical multiple myeloma research. In February 2008, the Company announced results of preclinical animal studies in which Senesco's Factor 5A technology, encapsulated in nanoparticles, was able to induce apoptosis in multiple myeloma tumors when injected intratumorally.

Senesco has continued its research in both preclinical animal models and human multiple myeloma cell lines, while also studying intravenous delivery of its therapy. In its previously announced preclinical testing and its recent expanded studies, the Company has used a combination therapy of its siRNA against Factor 5A, as well as a plasmid of the Factor 5A gene encapsulated in a nanoparticle.

Whether the combination therapy was injected intratumorally or systemically, human multiple myeloma tumors grown subcutaneously in the flanks of immunodeficient mice were reduced by approximately 95% versus tumors in untreated mice. Additionally, groups of treated mice were studied for up to three weeks after the last therapeutic injection and in mice whose tumors had regressed, the tumors did not regenerate.

In human multiple myeloma cell line studies, Senesco determined that its siRNA may sensitize cells for apoptosis through a reduction in activation of NFkB, a key inflammatory transcription factor. The siRNA also reduced levels of ICAM (intracellular adhesion molecule), a binding molecule, which is involved in promoting tissue inflammation.

The Company, together with its clinical research organization, is evaluating potential manufacturing centers for its materials, planning precli
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ECRI Institutes Alert and Recall Management System Expands Effectiveness with New Content and Filters
2. L&M Healthcare Communications LLC Expands With Hiring of New Executive Staff & Opening of Midwest Office
3. Milestone Scientific Expands Global Distribution Network
4. Life-Saving Technology Expands Globally to Military Branches - Transforming the Way Medical Care is Documented on the Battlefield
5. ACS Expands State Medicaid Presence with $156 Million Tennessee Contract
6. Chiltern Expands Its Global Reach to Latin America
7. Ralphs Expands Discounted Generic Drug Program
8. Food 4 Less Expands Discounted Generic Drug Program
9. ACORN Expands Presence in EDC Market with Commercialization of Guardian EDC(TM)
10. New Payroll Service Expands Selling Power and Service Capability of Employee Benefits Brokers
11. Tobacco Quit Line Expands Services for Pregnant Women Who Smoke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Sanjay Gupta, MD, CNN’s Emmy award-winning ... at ATA 2015, the American Telemedicine Association's (ATA) ... world’s largest telemedicine, telehealth and mHealth meeting. , ... for several of CNN’s headlining programs including New ... DuPont Award winning WEED series. He has created ...
(Date:3/6/2015)... Ticket Down is a reputable source for ... the Moda Center. After being away from the touring ... no signs of letting up on his “Garth Brooks World ... wife, Trisha Yearwood, to venues around the United States. The ... acclaimed tour to the Moda Center in Portland, OR. The ...
(Date:3/6/2015)... March 06, 2015 Ticket Down is a ... popular ticket exchange has extended their customer appreciation discount code ... Bridge, West Yorkshire England and he began his career in ... the past couple of years Ed Sheeran has become a ... Sheeran is on stage he is having the time of ...
(Date:3/6/2015)... 2015 At Natural Products Expo ... the launch of its powerful, location-aware iOS app ... sustainable products at any retailer that carries those ... Expo West Booth 6054. , Makeena’s proprietary ... non-GMO, organic, Paleo, and vegan, among many other ...
(Date:3/6/2015)... Many patients with knee osteoarthritis have ... you (or someone you know) have chronic pain and ... be interested in the ACT-OA clinical trial. , ... he is one of fifteen physicians in the U.S. ... subjects as part of a new, multi-site, double blind, ...
Breaking Medicine News(10 mins):Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2
... , , WALTHAM, Mass., ... country, often in dangerously hot weather conditions, Mobile Sports, Inc. ... iPhone application giving athletes, parents of athletes, coaches, and athletic ... and other, more serious heat-related illnesses. , ...
... , TEMPLE, Texas, Aug. 31 Scott & ... Texas Department of State Health Services for the next three years. Scott ... 2003. In May of this year, Scott & White Hospital was ... Surgeons Committee on Trauma (ACSCOT), the first step in receiving its official ...
... BEIJING, Aug. 31 /PRNewswire-Asia/ -- ... today that the Company,s,Chinese subsidiary, Beijing Rain and ... Municipal No.3 People,s Hospital ("HangZhou,No.3 Hospital"), entered into ... $4,800,000 RMB (approximately $703,000USD). , ...
... , ... as President of Health Science and Careers Division , ... New York (PRWEB) August 31, 2009 -- The education and technology ... Health Science and Careers division of its Professional & Career business., , , , ,Pearson,s ...
... , PARSIPPANY, N.J., Aug. 31 Endometrin(R) ... (progesterone gel) for progesterone supplementation, according to the results of ... increase endometrial receptivity for implantation of an embryo and to ... ENDOMETRIN(R) rapidly reached higher progesterone serum concentrations, produced greater systemic ...
... , , , , ... white after Labor Day," yet this rule is so passe. Don,t stick to ... a slave to fashion rules and have been spotted in white all year-round, ... wear the shade head-to-toe, you can wear white as you wish with a ...
Cached Medicine News:Health News:New Technology Helps Athletes Prevent Dehydration and Heat-Related Illness 2Health News:Scott & White Memorial Hospital Receives Level I Trauma Center Re-designation Again 2Health News:RainEarth (RNER) Signs Purchase Agreement with HangZhou Municipal No.3 People's Hospital 2Health News:RainEarth (RNER) Signs Purchase Agreement with HangZhou Municipal No.3 People's Hospital 3Health News:Pearson Announces Leah Jewell as President of Health Science and Careers Division 2Health News:Pearson Announces Leah Jewell as President of Health Science and Careers Division 3Health News:Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN(R) Over Crinone(R) for Progesterone Supplementation 2Health News:Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN(R) Over Crinone(R) for Progesterone Supplementation 3Health News:Photos: Breaking The 'No White After Labor Day' Fashion Myth 2
(Date:3/5/2015)... 2015 BioLineRx (NASDAQ: BLRX ... to identifying, in-licensing and developing promising therapeutic candidates, ... public offering of American Depositary Shares ("ADSs"), each ... of the ADSs in the offering are to ... Securities is acting as sole book-running manager for ...
(Date:3/5/2015)... Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... and year ended January 3, 2015.  , Revenues ... record for the Company and up 11% from $10.6 million ... million, also a record, up 12% from $38.3 million in ... was 50.1%, up from 48.6% in the fourth quarter of ...
(Date:3/5/2015)... March 5, 2015  BioPhotas, Inc., an FDA registered ... patented photo-therapeutic technologies to treat skin, muscle and joint ... Semper Fi Fund to provide BioPhotas, flagship product, the ... pain management solutions.  Commenting on the ... who used the Celluma at the Warrior Hope and ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3
... NEW YORK, Sept. 30 Law firm Clifford Chance, as ... its merger with Wyeth under China,s Anti-Monopoly Law. The clearance ... September 2009. , Competition approval from the Chinese authorities was ... , The EU has already approved the deal; decisions ...
... , LAKE FOREST, Ill., Sept. 30 Hospira, Inc. ... medication delivery company, today announced the acquisition of worldwide ... affiliated European manufacturing facility from PLIVA Hrvatska d.o.o. (Zagreb, ... Hospira,s reach and vertical integration in biogenerics. Financial ...
Cached Medicine Technology:Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 2Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA 2Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: